Hostname: page-component-5f56664f6-spj7j Total loading time: 0 Render date: 2025-05-07T21:08:35.526Z Has data issue: false hasContentIssue false

To evaluate the results of mastoid obliteration and reconstruction of posterior meatal wall after canal wall down mastoidectomy using ready-to-use, self-setting hydroxyapatite bone cement

Published online by Cambridge University Press:  25 October 2024

Salman Hashmi*
Affiliation:
Peterborough City Hospital, UK
Syed Zohaib Maroof Hussain
Affiliation:
Leicester Royal Infirmary, UK
Owais Matto
Affiliation:
Peterborough City Hospital, UK
Samuel Dewhurst
Affiliation:
Peterborough City Hospital, UK
Asad Qayyum
Affiliation:
Peterborough City Hospital, UK
*
Corresponding author: Salman Hashmi; Email: [email protected]

Abstract

Objectives

Despite a lot of scientific advancements in otology, canal wall-down mastoidectomy is still considered to be the standard of care in the management of extensive cholesteatoma. To avoid large cavity related problems, mastoid obliteration has been described in the literature for many decades. Controversy prevails among otologists regarding the materials used for obliteration. This study aimed to evaluate the results of mastoid obliteration and reconstruction of posterior meatal wall after mastoidectomy using ready-to-use, self-setting hydroxyapatite bone cement.

Methods

Retrospective analysis was performed of all consecutive patients who underwent canal wall down mastoidectomies and primary mastoid obliteration with ready-to-use, self-setting hydroxyapatite bone cement. Minimum follow-up was 1 year. Primary Outcome measures include need for explantation and post-operative complications.

Results

Total of 26 patients were included in the study. Only one patient required complete explantation. All patients acquired dry cavities in the final follow-up. Few minor complications including external auditory canal granulations and post-aural wound dehiscence. There was no cholesteatoma recidivism.

Conclusion

Ready-to-use, self-setting hydroxyapatite bone cement serves the purpose of mastoid obliteration. In addition, it is time efficient and requires less expertise. It has excellent outcomes in terms of cholesteatoma recidivism. We recommend further research in this area with a large cohort.

Type
Main Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

Footnotes

Salman Hashmi takes responsibility for the integrity of the content of the paper

References

van der Toom, HFE, van der Schroeff, MP, Pauw, RJ. Single-stage mastoid obliteration in cholesteatoma surgery and recurrent and residual disease rates: a systematic review. JAMA Otolaryngol Head Neck Surg 2018;144:440–6Google Scholar
el-Seifi, A, Fouad, B. Long-term fate of plastipore in the middle ear. ORL J Otorhinolaryngol Relat Spec 1998;60:198201Google Scholar
LeClair, KL, Bessen, SY, Rees, CA, Saunders, JE. Outcomes of a novel alloplastic technique for external auditory canal repair in tympanomastoidectomy. Laryngoscope Investig Otolaryngol 2020;5:743–9Google Scholar
Yung, MW. The use of hydroxyapatite granules in mastoid obliteration. Clin Otolaryngol Allied Sci 1996;21:480–4Google Scholar
Jeong, J, Kim, JH, Shim, JH, Hwang, NS, Heo, CY. Bioactive calcium phosphate materials and applications in bone regeneration. Biomater Res 2019;23:4Google Scholar
Shah, AM, Jung, H, Skirboll, S. Materials used in cranioplasty: a history and analysis. Neurosurg Focus 2014;36:E19Google Scholar
Stryker. A pre-clinical evaluation of a novel calcium phosphate bone cement: DirectInject®. In: https://cmf.stryker.com/assets/files/3q/directinject_biocomp_wp_vfinal.pdf [8 January 2021]Google Scholar
DirectInject [Internet]. In: https://cmf.stryker.com/products/directinject [30 August 2021]Google Scholar
Ridenour, JS, Poe, DS, Roberson, DW. Complications with hydroxyapatite cement in mastoid cavity obliteration. Otolaryngol Head Neck Surg 2008;139:641–5Google Scholar
Ramsey, MJ, Merchant, SN, McKenna, MJ. Postauricular periosteal-pericranial flap for mastoid obliteration and canal wall down tympanomastoidectomy. Otol Neurotol 2004;25:873–8Google Scholar
de Veij Mestdagh, PD, Colnot, DR, Borggreven, PA, Orelio, CC, Quak, JJ. Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery. Acta Otolaryngol 2017;137:690–4Google Scholar
Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. American academy of otolaryngology-head and neck surgery foundation, inc Otolaryngol Head Neck Surg 1995;113:186–7Google Scholar
Mosher, HP. A method of filling the excavated mastoid with a flap from the back of the auricle. Laryngoscope 1911;21:1158–63Google Scholar
Leonard, RB, Sauer, BW, Hulbert, SF, Per‐Lee, JH. Use of porous ceramics to obliterate mastoid cavities. J Biomed Mater Res 1973;7:8595Google Scholar
Choong, KWK, Kwok, MMK, Shen, Y, Gerard, J-M, Teh, BM. Materials used for mastoid obliteration and its complications: a systematic review. ANZ J Surg 2022;92:9941006Google Scholar
Skoulakis, C, Koltsidopoulos, P, Iyer, A, Kontorinis, G. Mastoid obliteration with synthetic materials: a review of the literature. J Int Adv Otol 2019;15:400–4Google Scholar
El-Sayed Abd Elbary, M, Nasr, WF, Sorour, SS. Platelet-rich plasma in reconstruction of posterior meatal wall after canal wall down mastoidectomy. Int Arch Otorhinolaryngol 2018;22:103–7Google Scholar
Cho, SW, Cho, Y-B, Cho, H-H. Mastoid obliteration with silicone blocks after canal wall down mastoidectomy. Clin Exp Otorhinolaryngol 2012;5:23–7Google Scholar